Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides.
about
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphomaA holistic approach to targeting disease with polymeric nanoparticlesAttachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA.Regeneration of mammalian cochlear and vestibular hair cells through Hes1/Hes5 modulation with siRNASurface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo.Synergistic tumor suppression by combined inhibition of telomerase and CDKN1AThe nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus.Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumorsRational design of a biomimetic cell penetrating peptide library.Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung.Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epitheliumPolymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicingEfficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers.Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis.Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery.Enhancing potency of siRNA targeting fusion genes by optimization outside of target sequence.Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization.Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery.Systemic delivery of blood-brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissueSystemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo.Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancerSite-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized Mice.Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial cell transplantation.Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer.Bioengineered nanoparticles for siRNA delivery.Strategies in biomimetic surface engineering of nanoparticles for biomedical applications.Therapeutic siRNA: principles, challenges, and strategies.Recent progress in copolymer-mediated siRNA delivery.Surface modification of nonviral nanocarriers for enhanced gene delivery.Mitochondria-targeted drug delivery system for cancer treatment.Crossing the barrier: treatment of brain tumors using nanochain particles.A complementary strategy for enhancement of nanoparticle intracellular uptake.Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery.Tumor-targeted delivery of siRNA using fatty acyl-CGKRK peptide conjugates.Engineering the RNA-Nanobio Interface.Two-stage nanoparticle delivery of piperlongumine and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) anti-cancer therapy.Roadmap for an early gene therapy for cystic fibrosis airway disease.Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies.Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities.
P2860
Q24595213-22D57A77-DAD3-44FD-8975-EF1D607D272DQ26865163-9D0DFC71-0A94-46FF-8294-515EAA4A8470Q27318674-99FDF92F-D98A-4867-B204-B79A2C8FEDFFQ30429653-347C87CC-AE74-46B5-8159-8DEFAEC231D1Q33821050-D4D4BC11-9802-4DB3-BA8B-3082338FD8BBQ34002435-19A8A941-06C1-4E24-8439-CAE1A1D1101CQ34180779-ABE8FE12-75E9-4542-87F0-96EC9D453AA3Q34379208-A702E0A7-E442-4D2B-9B7B-28AE22C220D5Q34991955-C711AAA0-3409-48AB-A09A-981DBE356707Q35117840-5FB2ABAD-1C79-4052-9D88-8683A254EA96Q35781735-D6D74FEB-3578-4B96-AC33-3AC3DA38C98CQ36004826-996D9EDF-53F9-4D67-AA6C-C0FA6C05E2A6Q36032436-3D8C632E-FAA6-4CFA-868C-EF8E308758A2Q36084803-AC18AD45-5B3E-4DB0-80CD-3F7049D060E1Q36161132-70591344-37D1-4FC4-AFD9-51101FAF2BADQ36354955-454BC69A-3FE9-40AD-95A7-B8D95A2DD8AEQ36414890-7B8FAEA5-CE53-487F-91A2-22A35B468513Q36763633-9CC5CE8A-3532-4461-91FA-0BECCB571CCBQ36881132-B2DE6589-8076-473C-B210-BE0A02E1327AQ37019421-A679F9CA-BD2F-4A4F-BDBC-2948FABEBCFAQ37274993-E457FD87-ACDC-4F32-B877-BB8C0A3817D2Q37467837-71870D63-95C7-4893-A0AD-CC87F0735A3BQ37503636-9C8B4B3A-B0C7-4766-86D6-BB5A40D13C8EQ37584464-BEAB6D3D-0757-414B-8088-F0EBC6AE0E30Q37679156-7CDB742F-D32C-4651-9CE8-5649EFBA25E2Q37963778-D1DE08EF-FE10-438C-8D6B-D24BB50F0408Q38021996-1CF40CED-87AD-46F3-ADFA-AFB2883269CDQ38023545-BEE38D08-85FB-4E1F-9BA9-A1F406DE3DADQ38172635-763C2132-D037-49C3-BC94-D91F1E0E03B0Q38628214-89FBF335-94D2-473D-A90C-7C1010285CD3Q38691508-DBAE4BCA-D9C1-4D7F-98D9-971A1A63C993Q39021925-34D2FCF7-7E0E-45C0-A515-21C4D94A3E08Q39247726-A6C46239-C9D0-4B42-B5F0-5B26DEEE2BF5Q41094538-29D56757-F64D-4093-8AD2-4266DE718CCCQ41513431-99571497-B11D-41C0-8FF2-2F6EB7A0B152Q41762619-3901DE4F-E92F-4EFE-9BD5-DBA1DC5CECE3Q41923573-3FF95CE5-6052-4805-BCAD-B7EFF6784D95Q42562347-A1F9F0D9-5FB4-45FB-91ED-2B24A5199436Q52743737-9FE24DA0-5184-4500-B89E-A4F6564EF060
P2860
Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Enhanced siRNA delivery into c ...... and cell-penetrating peptides.
@ast
Enhanced siRNA delivery into c ...... and cell-penetrating peptides.
@en
type
label
Enhanced siRNA delivery into c ...... and cell-penetrating peptides.
@ast
Enhanced siRNA delivery into c ...... and cell-penetrating peptides.
@en
prefLabel
Enhanced siRNA delivery into c ...... and cell-penetrating peptides.
@ast
Enhanced siRNA delivery into c ...... and cell-penetrating peptides.
@en
P2860
P1433
P1476
Enhanced siRNA delivery into c ...... and cell-penetrating peptides.
@en
P2093
Christopher J Cheng
W Mark Saltzman
P2860
P304
P356
10.1016/J.BIOMATERIALS.2011.04.053
P577
2011-06-12T00:00:00Z